Skip to main content
Erschienen in: Journal of Neurology 3/2014

01.03.2014 | Original Communication

GLUT1 deficiency syndrome into adulthood: a follow-up study

verfasst von: W. G. Leen, M. Taher, M. M. Verbeek, E. J. Kamsteeg, B. P. van de Warrenburg, M. A. Willemsen

Erschienen in: Journal of Neurology | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

GLUT1 deficiency syndrome (GLUT1DS) is a treatable neurometabolic disorder in which glucose transport into the brain is disturbed. Besides the classic phenotype of intellectual disability, epilepsy, and movement disorders, other phenotypes are increasingly recognized. These include, for example, idiopathic generalized epilepsy and paroxysmal exercise-induced dyskinesia. Since the disorder has only been recognized for two decades and is mostly diagnosed in children, little is known about the disease course. Our purpose was to investigate the disease course of GLUT1DS patients with the classic, complex phenotype from infancy into adulthood. We performed a systematic literature review as well as a cohort study, including GLUT1DS patients aged 18 years and older. The literature search yielded a total of 91 adult GLUT1DS patients, of which 33 patients (one-third) had a complex phenotype. The cohort study included seven GLUT1DS patients with a complex phenotype who were prospectively followed up in our clinic from childhood into adulthood. Our results show that epilepsy is a prominent feature during childhood in classic GLUT1DS patients. During adolescence, however, epilepsy diminishes or even disappears, but new paroxysmal movement disorders, especially paroxysmal exercise-induced dyskinesia, either appear or worsen if already present in childhood. Intellectual disability was not systematically assessed, but cognitive functions appeared to be stabile throughout life. Like children, adolescents may benefit from a ketogenic diet or variants thereof.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Pascual JM, Wang D, Lecumberri B et al (2004) GLUT1 deficiency and other glucose transporter diseases. Eur J Endocrinol 150:627–633CrossRefPubMed Pascual JM, Wang D, Lecumberri B et al (2004) GLUT1 deficiency and other glucose transporter diseases. Eur J Endocrinol 150:627–633CrossRefPubMed
2.
Zurück zum Zitat Wang D, Pascual JM, Yang H et al (2006) A mouse model for Glut-1 haploinsufficiency. Hum Mol Genet 15:1169–1179CrossRefPubMed Wang D, Pascual JM, Yang H et al (2006) A mouse model for Glut-1 haploinsufficiency. Hum Mol Genet 15:1169–1179CrossRefPubMed
3.
Zurück zum Zitat De Vivo DC, Trifiletti RR, Jacobson RI et al (1991) Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 325:703–709CrossRefPubMed De Vivo DC, Trifiletti RR, Jacobson RI et al (1991) Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 325:703–709CrossRefPubMed
4.
Zurück zum Zitat Klepper J (2008) Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet. Epilepsia 49(Suppl 8):46–49CrossRefPubMed Klepper J (2008) Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet. Epilepsia 49(Suppl 8):46–49CrossRefPubMed
5.
Zurück zum Zitat Pearson TS, Akman C, Hinton VJ, Engelstad K, De Vivo DC (2013) Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS). Curr Neurol Neurosci Rep 13:342CrossRefPubMed Pearson TS, Akman C, Hinton VJ, Engelstad K, De Vivo DC (2013) Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS). Curr Neurol Neurosci Rep 13:342CrossRefPubMed
6.
Zurück zum Zitat Tzadok M, Nissenkorn A, Porper K et al (2013) The many faces of Glut1 deficiency syndrome. J Child Neurol (Epub ahead of print) Tzadok M, Nissenkorn A, Porper K et al (2013) The many faces of Glut1 deficiency syndrome. J Child Neurol (Epub ahead of print)
7.
Zurück zum Zitat Arsov T, Mullen SA, Damiano JA et al (2012) Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency. Epilepsia 53:e204–e207CrossRefPubMed Arsov T, Mullen SA, Damiano JA et al (2012) Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency. Epilepsia 53:e204–e207CrossRefPubMed
8.
Zurück zum Zitat Arsov T, Mullen SA, Rogers S et al (2012) Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann Neurol 72:807–815CrossRefPubMed Arsov T, Mullen SA, Rogers S et al (2012) Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann Neurol 72:807–815CrossRefPubMed
9.
Zurück zum Zitat Suls A, Dedeken P, Goffin K et al (2008) Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 131:1831–1844PubMedCentralCrossRefPubMed Suls A, Dedeken P, Goffin K et al (2008) Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 131:1831–1844PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Afawi Z, Suls A, Ekstein D et al (2010) Mild adolescent/adult onset epilepsy and paroxysmal exercise-induced dyskinesia due to GLUT1 deficiency. Epilepsia 51:2466–2469CrossRefPubMed Afawi Z, Suls A, Ekstein D et al (2010) Mild adolescent/adult onset epilepsy and paroxysmal exercise-induced dyskinesia due to GLUT1 deficiency. Epilepsia 51:2466–2469CrossRefPubMed
11.
Zurück zum Zitat Roubergue A, Apartis E, Mesnage V et al (2011) Dystonic tremor caused by mutation of the glucose transporter gene GLUT1. J Inherit Metab Dis 34:483–488CrossRefPubMed Roubergue A, Apartis E, Mesnage V et al (2011) Dystonic tremor caused by mutation of the glucose transporter gene GLUT1. J Inherit Metab Dis 34:483–488CrossRefPubMed
12.
Zurück zum Zitat Flatt JF, Guizouarn H, Burton NM et al (2011) Stomatin-deficient cryohydrocytosis results from mutations in SLC2A1: a novel form of GLUT1 deficiency syndrome. Blood 118:5267–5277CrossRefPubMed Flatt JF, Guizouarn H, Burton NM et al (2011) Stomatin-deficient cryohydrocytosis results from mutations in SLC2A1: a novel form of GLUT1 deficiency syndrome. Blood 118:5267–5277CrossRefPubMed
13.
Zurück zum Zitat Weber YG, Kamm C, Suls A et al (2011) Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect. Neurology 77:959–964CrossRefPubMed Weber YG, Kamm C, Suls A et al (2011) Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect. Neurology 77:959–964CrossRefPubMed
14.
Zurück zum Zitat Mullen SA, Suls A, De Jonghe P, Berkovic SF, Scheffer IE (2010) Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency. Neurology 75:432–440CrossRefPubMed Mullen SA, Suls A, De Jonghe P, Berkovic SF, Scheffer IE (2010) Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency. Neurology 75:432–440CrossRefPubMed
16.
Zurück zum Zitat Leen WG, Mewasingh L, Verbeek MM et al (2013) Movement disorders in GLUT1 deficiency syndrome respond to the modified Atkins diet. Mov Disord 10:1439–1442CrossRef Leen WG, Mewasingh L, Verbeek MM et al (2013) Movement disorders in GLUT1 deficiency syndrome respond to the modified Atkins diet. Mov Disord 10:1439–1442CrossRef
17.
Zurück zum Zitat Ramm-Pettersen A, Nakken KO, Skogseid IM et al (2013) Good outcome in patients with early dietary treatment of GLUT-1 deficiency syndrome: results from a retrospective Norwegian study. Dev Med Child Neurol 55:440–447CrossRefPubMed Ramm-Pettersen A, Nakken KO, Skogseid IM et al (2013) Good outcome in patients with early dietary treatment of GLUT-1 deficiency syndrome: results from a retrospective Norwegian study. Dev Med Child Neurol 55:440–447CrossRefPubMed
18.
19.
Zurück zum Zitat Leen WG, Klepper J, Verbeek MM et al (2010) Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 133:655–670CrossRefPubMed Leen WG, Klepper J, Verbeek MM et al (2010) Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 133:655–670CrossRefPubMed
20.
Zurück zum Zitat Wang D, Pascual JM, Yang H et al (2005) Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol 57:111–118CrossRefPubMed Wang D, Pascual JM, Yang H et al (2005) Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol 57:111–118CrossRefPubMed
21.
Zurück zum Zitat Brockmann K (2009) The expanding phenotype of GLUT1-deficiency syndrome. Brain Dev 31:545–552CrossRefPubMed Brockmann K (2009) The expanding phenotype of GLUT1-deficiency syndrome. Brain Dev 31:545–552CrossRefPubMed
22.
Zurück zum Zitat Chugani HT (1998) A critical period of brain development: studies of cerebral glucose utilization with PET. Prev Med 27:184–188CrossRefPubMed Chugani HT (1998) A critical period of brain development: studies of cerebral glucose utilization with PET. Prev Med 27:184–188CrossRefPubMed
23.
Zurück zum Zitat Pascual JM, van Heertum RL, Wang D, Engelstad K, De Vivo DC (2002) Imaging the metabolic footprint of Glut1 deficiency on the brain. Ann Neurol 52:458–464CrossRefPubMed Pascual JM, van Heertum RL, Wang D, Engelstad K, De Vivo DC (2002) Imaging the metabolic footprint of Glut1 deficiency on the brain. Ann Neurol 52:458–464CrossRefPubMed
24.
Zurück zum Zitat Kluge A, Kettner B, Zschenderlein R et al (1998) Changes in perfusion pattern using ECD-SPECT indicate frontal lobe and cerebellar involvement in exercise-induced paroxysmal dystonia. Mov Disord 13:125–134CrossRefPubMed Kluge A, Kettner B, Zschenderlein R et al (1998) Changes in perfusion pattern using ECD-SPECT indicate frontal lobe and cerebellar involvement in exercise-induced paroxysmal dystonia. Mov Disord 13:125–134CrossRefPubMed
25.
Zurück zum Zitat Vissing J, Andersen M, Diemer NH (1996) Exercise-induced changes in local cerebral glucose utilization in the rat. J Cereb Blood Flow Metab 16:729–736CrossRefPubMed Vissing J, Andersen M, Diemer NH (1996) Exercise-induced changes in local cerebral glucose utilization in the rat. J Cereb Blood Flow Metab 16:729–736CrossRefPubMed
26.
Zurück zum Zitat Sadnicka A, Hoffland BS, Bhatia KP, van de Warrenburg BP, Edwards MJ (2012) The cerebellum in dystonia—help or hindrance? Clin Neurophysiol 123:65–70CrossRefPubMed Sadnicka A, Hoffland BS, Bhatia KP, van de Warrenburg BP, Edwards MJ (2012) The cerebellum in dystonia—help or hindrance? Clin Neurophysiol 123:65–70CrossRefPubMed
Metadaten
Titel
GLUT1 deficiency syndrome into adulthood: a follow-up study
verfasst von
W. G. Leen
M. Taher
M. M. Verbeek
E. J. Kamsteeg
B. P. van de Warrenburg
M. A. Willemsen
Publikationsdatum
01.03.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 3/2014
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7240-z

Weitere Artikel der Ausgabe 3/2014

Journal of Neurology 3/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.